49 results
8-K
EX-99.1
STOK
Stoke Therapeutics Inc
20 Nov 20
Stoke Therapeutics Announces Pricing of $97.5 Million Public Offering
4:08pm
Financial Services, Attention: Prospectus Department, 1155 Long Island Avenue, Edgewood, New York 11717, or by telephone: (866) 803-9204, or by emailing … prospectus-eq_fi@jpmchase.com; from Cowen and Company, LLC c/o Broadridge Financial Solutions, Attention: Prospectus Department, 1155 Long Island Avenue
CORRESP
STOK
Stoke Therapeutics Inc
14 Jun 19
Correspondence with SEC
12:00am
by the Corporate Financing Department of the Financial Industry Regulatory Authority that it has reviewed the above-captioned proposed offering
S-3
EX-1.2
v00w85xre
10 Jul 20
Shelf registration
4:06pm
PRE 14A
tcieo6b9qn4
17 Apr 23
Preliminary proxy
4:01pm
DRS
EX-10.6
dlcxu6mlp51q65c0ls
26 Mar 19
Draft registration statement
12:00am
S-1
EX-10.6
ogga1gq11h0w11r1 2g
23 May 19
IPO registration
4:02pm
S-1
EX-10.13
qbvjwi5i36mip9 arf
23 May 19
IPO registration
4:02pm
8-K
EX-4.1
ys32tqno06fws3
28 Mar 24
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
5:20pm